Literature DB >> 19226359

Nocturia: a non-specific but important symptom of urological disease.

Tim Schneider1, Jean J M C H de la Rosette, Martin C Michel.   

Abstract

Nocturia is a prevalent symptom that can adversely affect quality of sleep and overall quality of life leading to morbidity and even mortality. Nocturia can be due to a range of urological conditions and non-urological diseases. Nocturia can be due to an insufficient bladder capacity and/or (nocturnal) polyuria. Some of the possibly underlying non-urological diseases can be life-threatening, implying treatment priorities. Urological treatment options include alpha-adrenoceptor antagonists, muscarinic receptor antagonists and vasopressin receptor agonists. The former two have shown beneficial but small and inconsistent effects in patients assumed to have benign prostatic hyperplasia or overactive bladder, respectively. In contrast, the vasopressin analog desmopressin has consistently shown nocturia improvement in patients with proven polyuria. While supported by lower levels of evidence, lifestyle modifications are generally considered important for nocturia treatment. We conclude that nocturia is a urinary storage symptom with a major impact on patients' lives and a complex pathophysiology.

Entities:  

Mesh:

Year:  2009        PMID: 19226359     DOI: 10.1111/j.1442-2042.2008.02246.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  12 in total

1.  Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies.

Authors:  Andreas Eisenhardt; Tim Schneider; Francisco Cruz; Matthias Oelke
Journal:  World J Urol       Date:  2014-01-18       Impact factor: 4.226

Review 2.  Nocturia × disturbed sleep: a review.

Authors:  Daniele Furtado; Helena Hachul; Monica L Andersen; Rodrigo A Castro; Manoel B Girão; Sergio Tufik
Journal:  Int Urogynecol J       Date:  2011-08-17       Impact factor: 2.894

3.  The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia.

Authors:  Abul-Fotouh Ahmed; Aref Maarouf; Essam Shalaby; Ahmad H Gabr; Ashraf Shahin; Ammar Ghobish
Journal:  World J Urol       Date:  2014-08-20       Impact factor: 4.226

4.  Overactive bladder in males.

Authors:  Roger R Dmochowski; Alex Gomelsky
Journal:  Ther Adv Urol       Date:  2009-10

5.  Nocturia: focus on etiology and consequences.

Authors:  Jeffrey P Weiss
Journal:  Rev Urol       Date:  2012

6.  Correlation between Nocturia and Sleep: A Questionnaire Based Analysis.

Authors:  Seok Seon Yoo; Bong Suk Shim; Dong Hyeon Lee; Hyang Woon Lee; Hana Yoon
Journal:  Korean J Urol       Date:  2010-11-17

Review 7.  LUTS and sleep disorders: emerging risk factor.

Authors:  Omer Onur Cakir; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

8.  Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency.

Authors:  Jeffrey P Weiss; Zhanna Jumadilova; Theodore M Johnson; Mary P Fitzgerald; Martin Carlsson; Diane L Martire; Atul Malhotra
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

Review 9.  Desmopressin for treating nocturia in men.

Authors:  Julia Han; Jae Hung Jung; Caitlin J Bakker; Mark H Ebell; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2017-10-21

10.  Efficacy of desmopressin in treatment of nocturia in elderly men.

Authors:  Bijan Rezakhaniha; Nahid Arianpour; Soheila Siroosbakhat
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.